Understanding Hemophilia A and B Drug Dosage Administration Patterns

Stopped Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on March 21, 2018. See details in Description section.

Conditions

• Hemophilia A
• Hemophilia B

Interventions

• DRUG: Hemophilia B standard half-life
• DRUG: Hemophilia B extended half-life
• DRUG: Hemophilia A standard half-life
• DRUG: Hemophilia A extended half-life

Sponsor

Pfizer